Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_assertion type Assertion NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_head.
- NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_assertion description "[A population-attributable risk of approximately 50% for the Pro12Pro genotype indicates that testing for the Pro12Ala of the PPARG gene in addition to the already identified clinical risk factors may become a useful tool to further reduce the risk of PPARgamma agonist-induced fluid retention and edema in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_provenance.
- NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_assertion evidence source_evidence_literature NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_provenance.
- NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_assertion SIO_000772 16822823 NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_provenance.
- NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_assertion wasDerivedFrom gad-20130706 NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_provenance.
- NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_assertion wasGeneratedBy ECO_0000203 NP66286.RAcX9HLwWZ1IkRutLp82j39dbKLhGkW2aqhsEks946GL8130_provenance.